| 名稱(chēng) | BCR-ABL1 P223S/BaF3 |
| 型號(hào) | CBP73310 |
| 報(bào)價(jià) | ![]() |
| 特點(diǎn) | BCR-ABL1 [P223S]/BaF3,母細(xì)胞:BaF3,凍存條件:90% FBS+10% DMSO; |
產(chǎn)品搜索
產(chǎn)品分類(lèi)
相關(guān)文章
- 新加坡科學(xué)家找到治療侵襲性卵巢癌的新可能
- 腫瘤細(xì)胞的凋亡與壞死有何區(qū)別?
- ADCC/ADCP細(xì)胞篩選模型
- 增強(qiáng)腫瘤免疫療法新靶點(diǎn):ADORA2B(腺苷A2B受體)
- 喝熱茶或使食管癌風(fēng)險(xiǎn)增加5倍
- 從諾輝財(cái)報(bào)看甲基化市場(chǎng),科佰生物助力甲基化標(biāo)準(zhǔn)品的開(kāi)發(fā)
- A2A受體家族細(xì)胞篩選模型
- CD200/CD200R篩選模型
- DPCR檢測(cè)試劑盒開(kāi)發(fā)性能驗(yàn)證
- 3年回顧,賀教授敲錯(cuò)了基因?CXCR4 or CCR5
聯(lián)系我們
電話:4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > kinase激酶細(xì)胞株 > CBP73310BCR-ABL1 P223S/BaF3
- 詳細(xì)內(nèi)容
| CBP73310 | |
| I. Introduction | |
Cell Line Name: | BCR-ABL1 [P223S]/BaF3 |
Host Cell: | Ba/F3 |
| Stability: | 16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Application: | Anti-proliferation assay and PD assay |
Freeze Medium: | 90% FBS+10% DMSO |
Complete Culture Medium: | RPMI-1640+10%FBS |
Mycoplasma Status: | Negative |
| II.Background | |
Presence of a BCR-ABL1 fusion gene is necessary for the pathogenesis of CML. In up to 95% of cases, a t(9;22) (q34;q11) translocation results in the BCR-ABL1 fusion gene (Faderl et al. 1999). This translocation results in the Philadephia chromosome. In rare CML cases lacking the traditional t(9;22) translocation, other translocations result in the creation of the BCR-ABL1 fusion gene, which sometimes involve multiple chromosomes. | |
| III. Representative Data | |
1.WB of BCR-ABL1 [P223S]/BaF3
| |
2.Sanger of BCR-ABL1 [P223S]/BaF3 Figure 2. BCR-ABL1 [P223S]/BaF3 P223S Figure 3. BCR-ABL1 [P223S]/BaF3 Fusion | |
3. Anti-proliferation assay
Figure 4. CTG Proliferation Assay of BaF3 BCR-ABL1 P223S Cells (C14). | |








會(huì)員_a.png)